# Ketamine for Refractory Chronic Migraine: a Pilot Study

> **NCT03896256** · EARLY_PHASE1 · COMPLETED · sponsor: **Thomas Jefferson University** · enrollment: 6 (actual)

## Conditions studied

- Migraine Headache With Intractable Migraine

## Interventions

- **DRUG:** ketamine infusion

## Key facts

- **NCT ID:** NCT03896256
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-22
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03896256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03896256, "Ketamine for Refractory Chronic Migraine: a Pilot Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03896256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*